Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort.
Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort.
复制标题
DOI：
10.1186/s12885-018-4942-0
复制
发表时间：
2018-11-03
期刊：
影响因子：
3.8
通讯作者：
Morales KH
中科院分区：
文献类型：
--
作者：
Zeigler-Johnson C;Hudson A;Glanz K;Spangler E;Morales KH
Obesity has been associated with aggressive prostate cancer and poor outcomes. It is important to understand how prognostic tools for that guide prostate cancer treatment may be impacted by obesity. The goal of this study was to evaluate the predicting abilities of two prostate cancer (PCa) nomograms by obesity status. We examined 1576 radical prostatectomy patients categorized into standard body mass index (BMI) groups. Patients were categorized into low, medium, and high risk groups for the Kattan and CaPSURE/CPDR scores, which are based on PSA value, Gleason score, tumor stage, and other patient data. Time to PCa recurrence was modeled as a function of obesity, risk group, and interactions. As expected for the Kattan score, estimated hazard ratios (95% CI) indicated higher risk of recurrence for medium (HR = 2.99, 95% CI = 2.29, 3.88) and high (HR = 8.84, 95% CI = 5.91, 13.2) risk groups compared to low risk group. The associations were not statistically different across BMI groups. Results were consistent for the CaPSURE/CPDR score. However, the difference in risk of recurrence in the high risk versus low risk groups was larger for normal weight patients than the same estimate in the obese patients. We observed no statistically significant difference in the association between PCa recurrence and prediction scores across BMI groups. However, our study indicates that there may be a stronger association between high risk status and PCa recurrence among normal weight patients compared to obese patients. This suggests that high risk status based on PCa nomogram scores may be most predictive among normal weight patients. Additional research in this area is needed.
登录
查看更多内容
影响因子：
3.8
作者：
Rodriguez, Carmen;Freedland, Stephen J.;Calle, Eugenia E.
通讯作者：
Calle, Eugenia E.
影响因子：
6.6
作者：
Spangler, E.;Zeigler-Johnson, C. M.;Rebbeck, T. R.
通讯作者：
Rebbeck, T. R.
影响因子：
4.5
作者：
Korets, Ruslan;Motamedinia, Piruz;McKiernan, James M.
通讯作者：
McKiernan, James M.
影响因子：
23.4
作者：
Isbarn, Hendrik;Boccon-Gibod, Laurent;Carroll, Peter R.;Montorsi, Francesco;Schulman, Claude;Smith, Matthew R.;Sternberg, Cora N.;Studer, Urs E.
通讯作者：
Studer, Urs E.
影响因子：
45.3
作者：
Amling, CL;Riffenburgh, RH;McLeod, DG
通讯作者：
McLeod, DG